PKM and neuroblastoma: Similarly, the PKM2/PKM1 ratio was considerably decreased by OCT4-binding inhibition in this study (Figure 3D), suggesting that the splicing switch from PKM1 to PKM2 underlies the mechanism of inhibition of NB proliferation after transfection of CRISPR/dCas9 targeting the OCT4-binding site.